Prescription Items Prescription items will be sent on receipt of a legally valid signed and dated prescription
Retatrutide (Phase 2): A 48-week Phase 2 trial reported mean weight reductions of up to 24.2% from baseline at the highest dose
The fight against obesity and its associated health risks is a multifaceted challenge that requires a combination of medical intervention, lifestyle changes, and societal support to achieve lasting success
Patients with a history of acute or chronic pancreatitis were excluded from SURMOUNT-1 and the major semaglutide trials
Glutathione, known as a potent antioxidant, works at the cellular level to support skin radiance, detoxification, and overall health
Supported by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892